Evidence map›Paper›PMID 29233145›Full record

ArticleJournal of biomedical science2017

Suppression of interleukin-6 increases enterovirus A71 lethality in mice.

Li-Chiu Wang, Hui-Wen Yao, Chuan-Fa Chang, Shainn-Wei Wang, Shih-Min Wang, Shun-Hua Chen

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Li-Chiu WangInstitute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan, 701, Republic of China.
Hui-Wen YaoCenter of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan, 701, Republic of China.
Chuan-Fa ChangCenter of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan, 701, Republic of China.
Shainn-Wei WangCenter of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan, 701, Republic of China.
Shih-Min WangCenter of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan, 701, Republic of China.
Shun-Hua ChenCenter of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan, 701, Republic of China. shunhua@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0002-4585-9279
National Cheng Kung University · TW

Funding

Ministry of Science and Technology, Taiwan (TW) MOST 106-2321-B-006 -001
6 · The paper itself

Abstract

backgroundEnterovirus A71 (EV-A71) infection can induce fatal encephalitis in young children. Clinical reports show that interleukin-6 (IL-6) levels in the serum and cerebrospinal fluid of infected patients with brainstem encephalitis are significantly elevated. We used a murine model to address the significance of endogenous IL-6 in EV-A71 infection.

resultsEV-A71 infection transiently increased serum and brain IL-6 protein levels in mice. Most importantly, absence of IL-6 due to gene knockout or depletion of IL-6 using neutralizing monoclonal antibody enhanced the mortality and tissue viral load of infected mice. Absence of IL-6 increased the damage in the central nervous system and decreased the lymphocyte and virus-specific antibody responses of infected mice.

conclusionsEndogenous IL-6 functions to clear virus and protect the host from EV-A71 infection. Our study raises caution over the use of anti-IL-6 antibody or pentoxifylline to reduce IL-6 for patient treatment.

Indexed as

Interleukin-6 InhibitorsViral LoadAnimalsAntibodies, NeutralizingAntibodies, ViralCell Line, TumorEnterovirus A, HumanHumansInterleukin-6MiceMice, Inbred C57BLAntibodies, NeutralizingAntibodies, ViralInterleukin-6Interleukin-6 Inhibitorsinterleukin-6, mouseEnterovirus A71 and interleukin-6

Identifiers

PMID29233145
PMCPMC5726025
OpenAlexW2775628355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.